HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $318,000 | -50.3% | 6,000 | +4.2% | 0.01% | -61.5% |
| Q1 2021 | $640,000 | -32.6% | 5,760 | -47.0% | 0.01% | -45.8% |
| Q3 2020 | $949,000 | -88.4% | 10,868 | -88.1% | 0.02% | -83.1% |
| Q2 2020 | $8,171,000 | +177.6% | 91,237 | +256.2% | 0.14% | +222.7% |
| Q4 2019 | $2,943,000 | +51.8% | 25,617 | +66.7% | 0.04% | +10.0% |
| Q3 2019 | $1,939,000 | +132.8% | 15,371 | +61.3% | 0.04% | +100.0% |
| Q1 2019 | $833,000 | -47.3% | 9,530 | -31.0% | 0.02% | -31.0% |
| Q3 2018 | $1,582,000 | +649.8% | 13,803 | +192.8% | 0.03% | +866.7% |
| Q3 2017 | $211,000 | -31.0% | 4,714 | -50.3% | 0.00% | -57.1% |
| Q3 2015 | $306,000 | -61.5% | 9,493 | -50.6% | 0.01% | -53.3% |
| Q2 2015 | $795,000 | -26.3% | 19,218 | -25.0% | 0.02% | -72.2% |
| Q4 2013 | $1,079,000 | +365.1% | 25,611 | +356.3% | 0.05% | +315.4% |
| Q2 2013 | $232,000 | – | 5,613 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |